Notice: This company has been marked as potentially delisted and may not be actively trading. BioTelemetry (BEAT) Short Interest Ratio & Short Volume Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsCompetitorsEarningsHeadlinesInsider TradesShort InterestTrends BioTelemetry Short Interest DataBioTelemetry (BEAT) has a short interest of 229,400 shares, representing 0.94% of the float (the number of shares available for trading by the public). This marks a 4.99% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.4, indicating that it would take 1.4 days of the average trading volume of 112,382 shares to cover all short positions.Current Short Interest229,400 sharesPrevious Short Interest218,500 sharesChange Vs. Previous Month+4.99%Dollar Volume Sold Short$456,506.00Short Interest Ratio1.4 Days to CoverLast Record DateFebruary 28, 2025Outstanding Shares26,670,000 sharesFloat Size24,520,000 sharesShort Percent of Float0.94%Today's Trading Volume118,715 sharesAverage Trading Volume112,382 sharesToday's Volume Vs. Average106% Short Selling BioTelemetry? Sign up to receive the latest short interest report for BioTelemetry and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBEAT Short Interest Over TimeBEAT Days to Cover Over TimeBEAT Percentage of Float Shorted Over Time Remove Ads BioTelemetry Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 2/28/2025229,400 shares $456,506.00 +5.0%0.9%1.4 $1.99 2/15/2025218,500 shares $469,556.50 -23.5%1.1%1.3 $2.15 1/31/2025285,600 shares $682,584.00 -2.3%1.5%1.7 $2.39 1/15/2025292,200 shares $610,698.00 -15.4%1.5%1.8 $2.09 12/31/2024345,400 shares $746,064.00 +100.5%1.8%2.2 $2.16 12/15/2024172,300 shares $537,576.00 +26.7%0.9%1.1 $3.12 11/30/2024136,000 shares $416,160.00 +78.7%0.7%1.4 $3.06 11/15/202476,100 shares $174,269.00 -51.2%0.4%0.9 $2.29 10/31/2024155,900 shares $377,278.00 +24.5%0.8%2.2 $2.42 10/15/2024125,200 shares $287,960.00 -7.2%0.6%1.9 $2.30 Get the Latest News and Ratings for BEAT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BioTelemetry and its competitors with MarketBeat's FREE daily newsletter. 9/30/2024134,900 shares $312,968.00 +64.3%0.7%2.2 $2.32 9/15/202482,100 shares $181,441.00 -30.5%0.4%1.2 $2.21 8/31/2024118,200 shares $277,770.00 -34.2%0.6%1.5 $2.35 8/15/2024179,700 shares $415,107.00 -9.0%0.9%1.7 $2.31 7/31/2024197,400 shares $515,214.00 -42.4%1.0%1.7 $2.61 7/15/2024342,600 shares $993,540.00 +33.6%1.8%3.1 $2.90 6/30/2024256,500 shares $659,205.00 -4.8%1.3%2.2 $2.57 6/15/2024269,500 shares $619,850.00 +90.5%1.4%2.7 $2.30 5/31/2024141,500 shares $393,370.00 +165.5%0.7%1.2 $2.78 5/15/202453,300 shares $114,595.00 -55.1%0.3%0.4 $2.15 4/30/2024118,600 shares $238,386.00 -14.5%0.6%1 $2.01 4/15/2024138,700 shares $255,208.00 -13.0%0.7%1.1 $1.84 3/31/2024159,400 shares $347,492.00 +20.7%0.8%1.2 $2.18 3/15/2024132,100 shares $318,361.00 +247.6%0.7%0.4 $2.41 2/29/202438,000 shares $55,100.00 -13.8%0.2%0.1 $1.45 2/15/202444,100 shares $79,380.00 +13.4%0.2%0.2 $1.80 1/31/202438,900 shares $72,743.00 -37.3%0.2%0.2 $1.87 1/15/202462,000 shares $104,160.00 -62.3%0.3%0.3 $1.68 12/31/2023164,500 shares $386,575.00 +383.8%0.8%0.7 $2.35 12/15/202334,000 shares $42,500.00 +21.9%0.2%0.2 $1.25 11/30/202327,900 shares $40,455.00 -44.6%0.1%0.5 $1.45 11/15/202350,400 shares $61,488.00 +3.9%0.3%0.9 $1.22 10/31/202348,500 shares $60,140.00 -12.8%0.3%0.9 $1.24 10/15/202355,600 shares $81,732.00 -25.0%0.3%1.1 $1.47 9/30/202374,100 shares $159,315.00 -3.9%0.4%1.2 $2.15 9/15/202377,100 shares $189,666.00 +15.9%0.4%0.9 $2.46 8/31/202366,500 shares $138,985.00 -14.9%0.4%0.6 $2.09 8/15/202378,100 shares $194,469.00 -40.1%0.4%0.2 $2.49 7/31/2023130,400 shares $396,416.00 -18.9%2.2%0.3 $3.04 7/15/2023160,700 shares $515,847.00 +31.5%2.7%0.3 $3.21Forget the chainsaw … Here’s DOGE’s next move (Ad)Donald Trump, Elon Musk and the Department of Government Efficiency have kept their word. Moving even faster than most people thought … Clearing out waste and inefficiency in our government.Click here to find out when DOGE is expected to act. 6/30/2023122,200 shares $294,502.00 -4.8%2.0%0.2 $2.41 6/15/2023128,300 shares $346,410.00 -29.6%2.1%0.3 $2.70 5/31/2023182,200 shares $428,170.00 +103.8%16.7%0.4 $2.35 5/15/202389,400 shares $193,998.00 No Change3.8%1.3 $2.17 10/31/2022347,000 shares $1.16 million -5.0%9.3%0.1 $3.33 10/15/2022365,400 shares $1.41 million -29.5%9.7%0.1 $3.87 9/30/2022518,000 shares $2.02 million +1,367.4%13.8%0.1 $3.90 9/15/202235,300 shares $81,896.00 -46.1%0.9%0 $2.32 8/31/202265,500 shares $83,840.00 +26.2%1.8%0.7 $1.28 8/15/202251,900 shares $80,445.00 -38.5%1.4%0.6 $1.55 7/31/202284,400 shares $119,004.00 +8.3%2.3%1.2 $1.41 7/15/202277,900 shares $105,944.00 -7.2%2.1%1.1 $1.36 6/30/202283,900 shares $108,231.00 -17.8%2.1%0.5 $1.29 6/15/2022102,000 shares $132,600.00 -5.9%2.6%0.7 $1.30 5/31/2022108,400 shares $157,180.00 +43.6%2.7%0.7 $1.45 5/15/202275,500 shares $101,925.00 -34.9%1.9%0.5 $1.35 4/30/2022115,900 shares $158,783.00 +26.7%3.0%0.7 $1.37 4/15/202291,500 shares $147,315.00 -13.2%2.4%0.5 $1.61 3/31/2022105,400 shares $194,357.60 +100.4%N/A1 $1.84 3/15/202252,600 shares $87,842.00 +9.1%1.4%0.2 $1.67 2/28/202248,200 shares $84,350.00 -32.8%1.3%0.2 $1.75 2/15/202271,700 shares $126,192.00 -50.3%1.9%0.3 $1.76 1/31/2022144,200 shares $312,914.00 +29.4%3.8%0.4 $2.17 1/15/2022111,400 shares $357,594.00 +62.4%N/A0.3 $3.21 12/31/202168,600 shares $211,288.00 No Change1.8%0.2 $3.08 1/29/20211,100,000 shares $79.24 million -49.1%3.3%1.3 $72.04 1/15/20212,160,000 shares $155.82 million +3.4%6.5%3.1 $72.14 12/31/20202,090,000 shares $150.48 million -31.3%6.3%3.3 $72.00 12/15/20203,040,000 shares $183.77 million -13.6%9.2%5.8 $60.45 11/30/20203,520,000 shares $189.87 million -0.9%10.6%10.6 $53.94 11/15/20203,550,000 shares $168.63 million -7.8%10.7%10.9 $47.50 10/30/20203,850,000 shares $160.58 million +8.8%11.6%12.1 $41.71 10/15/20203,540,000 shares $157.74 million -9.2%10.7%10.2 $44.56 9/30/20203,900,000 shares $177.76 million -1.8%11.8%11 $45.58 9/15/20203,970,000 shares $161.62 million -0.3%12.0%10.5 $40.71 8/31/20203,980,000 shares $157.53 million +5.6%12.0%11.5 $39.58 8/14/20203,770,000 shares $162.45 million +18.9%11.4%11.3 $43.09 7/31/20203,170,000 shares $134.92 million +6.4%9.6%9.3 $42.56 7/15/20202,980,000 shares $123.19 million +13.7%9.0%9.2 $41.34 6/30/20202,620,000 shares $118.40 million +24.8%7.9%8 $45.19 6/15/20202,100,000 shares $97.31 million +2.4%6.4%6.4 $46.34 5/29/20202,050,000 shares $96.72 million +3.0%6.2%5.7 $47.18 5/15/20201,990,000 shares $82.64 million -10.0%6.0%5.1 $41.53 4/30/20202,210,000 shares $103.23 million -4.3%6.7%6 $46.71 4/15/20202,310,000 shares $102.61 million +3.1%7.0%6.7 $44.42 3/31/20202,240,000 shares $86.26 million -16.6%6.8%6.6 $38.51 3/13/20202,686,100 shares $98.93 million +7.0%8.2%7 $36.83 BEAT Short Interest - Frequently Asked Questions What is BioTelemetry's current short interest? Short interest is the volume of BioTelemetry shares that have been sold short but have not yet been closed out or covered. As of February 28th, traders have sold 229,400 shares of BEAT short. 0.94% of BioTelemetry's shares are currently sold short. Learn More on BioTelemetry's current short interest. What is a good short interest ratio for BioTelemetry? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BEAT shares currently have a short interest ratio of 1.0. Learn More on BioTelemetry's short interest ratio. What is a good short interest percentage for BioTelemetry? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.94% of BioTelemetry's floating shares are currently sold short. Is BioTelemetry's short interest increasing or decreasing? BioTelemetry saw a increase in short interest in February. As of February 28th, there was short interest totaling 229,400 shares, an increase of 5.0% from the previous total of 218,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is BioTelemetry's float size? BioTelemetry currently has issued a total of 26,670,000 shares. Some of BioTelemetry's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. BioTelemetry currently has a public float of 24,520,000 shares. How does BioTelemetry's short interest compare to its competitors? 0.94% of BioTelemetry's shares are currently sold short. Here is how the short interest of companies in the industry of "surgical & medical instruments" compare to BioTelemetry: Nevro Corp. (5.02%), Profound Medical Corp. (1.60%), Alpha Tau Medical Ltd. (0.15%), Utah Medical Products, Inc. (2.15%), Accuray Incorporated (4.37%), BrainsWay Ltd. (0.36%), TriSalus Life Sciences, Inc. (1.07%), The Beauty Health Company (11.60%), LENSAR, Inc. (1.15%), Orchestra BioMed Holdings, Inc. (1.97%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($23.74 billion), iShares 20+ Year Treasury Bond ETF ($10.75 billion), MicroStrategy Incorporated ($6.56 billion), Apollo Global Management, Inc. ($5.40 billion), Charter Communications, Inc. ($4.57 billion), AppLovin Co. ($4.45 billion), Capital One Financial Co. ($4.33 billion), Super Micro Computer, Inc. ($4.23 billion), Schlumberger Limited ($3.22 billion), and Royal Caribbean Cruises Ltd. ($3.06 billion). View all of the most shorted stocks. What does it mean to sell short BioTelemetry stock? Short selling BEAT is an investing strategy that aims to generate trading profit from BioTelemetry as its price is falling. BEAT shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against BioTelemetry? A short squeeze for BioTelemetry occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BEAT, which in turn drives the price of the stock up even further. How often is BioTelemetry's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BEAT, twice per month. The most recent reporting period available is February, 28 2025. More Short Interest Resources from MarketBeat Related Companies Nevro Short Interest Profound Medical Short Interest Alpha Tau Medical Short Interest Utah Medical Products Short Interest Accuray Short Interest BrainsWay Short Interest TriSalus Life Sciences Short Interest Beauty Health Short Interest LENSAR Short Interest Orchestra BioMed Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BEAT) was last updated on 3/12/2025 by MarketBeat.com Staff From Our PartnersDeFi Coin on Verge of Breakout!We’re Opening the Ultimate Crypto Vault… Don't let this be the missed opportunity you regret for years. Crypto 101 Media | SponsoredNow that Trump’s be inaugurated, this day will be key (mark your calendar)Mark your calendar for March 13th. Because on that day, I believe we could see a $2 Trillion shock INTO the...Timothy Sykes | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredDOGE’s Next Move: Not what you thinkDonald Trump, Elon Musk and the Department of Government Efficiency have kept their word. Moving even faste...Weiss Ratings | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioTelemetry, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioTelemetry With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
